Related Experiment Video

Updated: Dec 7, 2025

Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines
12:06

Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines

Published on: November 25, 2017

13.1K

Targeting N-acetylgalactosaminyltransferase for anticancer therapy

Parteek Prasher1,2, Mousmee Sharma1,3

  • 1Department of Chemistry, UGC Sponsored Centre for Advanced Studies, Guru Nanak Dev University, Amritsar, India.

Drug Development Research
|September 28, 2020
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.3K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

7.9K

Related Experiment Videos

Last Updated: Dec 7, 2025

Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines
12:06

Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines

Published on: November 25, 2017

13.1K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.3K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

7.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.4K

Articles linked to this work by shared authors, journal, and citation graph.

Exploring the Therapeutic Potential of Nobiletin in Nonsmall Cell Lung Cancer.

BioMed research international·2026

Correction: Bakshi et al. Dietary Crocin is Protective in Pancreatic Cancer while Reducing Radiation-Induced Hepatic Oxidative Damage. Nutrients 2020, 12, 1901.

Nutrients·2025

Synthesis and release studies on amylose-based ester prodrugs of fenamic acid NSAIDs.

Therapeutic delivery·2024

Starch-based "smart" nanomicelles: Potential delivery systems for doxorubicin.

Drug development research·2024

The contemplation of amylose for the delivery of ulcerogenic nonsteroidal anti-inflammatory drugs.

Future medicinal chemistry·2024

Synthesis and evaluation of amylose-mefenamic acid conjugates as colon-targeting prodrugs.

Therapeutic delivery·2024

GRP78 Drives NSCLC Stemness and EMT via a SIX1/β-Catenin Signaling Axis.

Drug development research·2026

Applications of Bioinorganic Nano-Based Delivery Systems-Diagnostics and Therapeutics.

Drug development research·2026

TrxR Inhibition and Nrf2-FOXO3 Modulation by Repurposed Drugs: A Redox Strategy to Reverse Cancer Multidrug Resistance.

Drug development research·2026

RETRACTION: Reprogramming the Tumor Microenvironment: Calebin A as a Polyphenolic Paradigm Shift in Controlling Inflammation, Stemness, and Resistance in Colorectal Cancer.

Drug development research·2026

Two Novel 1,4-Naphthoquinone Derivatives as Potent Agents Against Multidrug-Resistant Staphylococcus aureus and Pathogenic Gram-Positive Bacteria.

Drug development research·2026

Discovery of a Potent and Selective MAO-B Inhibitor From a Donepezil-Linked Chalcone Library With Promising Antiparkinsonian Activity.

Drug development research·2026

Nanomaterials as plant delivery carriers: transport mechanisms and design principles.

Science China. Life sciences·2026

Titanium nitride nanoparticles for laser nanowarming in cryopreservation.

Biomaterials science·2026

Hyaluronic acid-engineered copper sulfide nanoparticles as immunomodulatory metal sulfide photothermal agents for macrophage-assisted osteosarcoma therapy.

Materials today. Bio·2026

Kinetically controlled shock-wave route to turbostratic boron-carbon-nitride nanosheets.

iScience·2026

Range of dose enhancement factor for gold nanoparticles in radiotherapy using Monte Carlo simulations.

Radiation and environmental biophysics·2026

Nano MIPs (Molecularly Imprinted Polymers) Prepared From a "Frustrated" Gold Nanoparticle-Based Pre-Imprinting Matrix: Enhancing Binding Affinity and Selectivity.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us